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Abstract
Background: Lipid metabolites and cytokines, including chemokines and growth factors, are the key regulators of
immune cell function and differentiation, and thus, dysregulation of these regulators is associated with various
human diseases. However, previous studies demonstrating a positive correlation of cytokine levels with aging may
have been influenced by various environmental factors and underlying diseases. Also, data regarding cytokine
profiling in the elderly are limited to a small subset of cytokines.
Methods: We compared the profiles of 22 cytokines, including chemokines and growth factors, in a case-
controlled study group of a gender-matched, healthy cohort of 55 patients over the age of 65 and 55 patients
under the age of 45. Assessment of serum cytokine concentrations was performed using commercially-available
multiplex bead-based sandwich immunoassays.
Results: Soluble CD40 ligand (sCD40L) and transforming growth factor alpha (TGF-a) levels were significantly
higher in the elderly patients, whereas granulocyte colony-stimulating factor (G-CSF), granulocyte-monocyte
colony-stimulating factor (GM-CSF), and monocyte chemoattractant protein-1 (MCP-1) levels were significantly
lower in the elderly patients. The partial correlation analysis demonstrating the correlation between cytokine levels
when controlled for gender, systolic blood pressure, total cholesterol, HDL cholesterol, triglyceride, and serum
creatinine levels further demonstrated that G-CSF, GM-CSF, and MCP-1 had significant negative correlations with
age, whereas sCD40L and TGF-a had significant positive correlations.
Conclusions: Future studies will focus on examining the significance of these age-related changes in circulating
cytokines and other biological markers and their potential contribution to the development of different age-
associated diseases.
Background
Aging is accompanied by a decline in immune functions,
referred to as immune aging or immune senescence. Para-
doxically, life-long exposure to environmental factors and
countless interactions with infectious agents leads to a
chronic inflammatory state in older individuals, termed
inflammaging, characterized by an increase in proinflam-
matory mediators present in serum [1,2]. Changes in T-
cell homeostasis with aging are associated with a decline
in immunity and increased inflammation. Increased
accumulation of regulatory T cells contributes to impaired
CD8 and natural killer cell activities [3,4]. Also, a decrease
in naïve T cells may result in impaired acquired immune
responses, whereas clonal expansion of CD25 null T cells
may result in increased secretion of tumor necrosis factor-
alpha (TNF-a) and interleukin-6 (IL-6), resulting in a
heightened degree of inflammation [5].
Lipid metabolites and cytokines, including chemokines
and growth factors, are the key regulators of immune cell
function and differentiation. Thus, dysregulation of these
regulators is associated with various human diseases.
Age-associated elevation of inflammatory factors includ-
ing TNF-a, IL-6, prostaglandin E2 (PGE2), and IL-1b
have been described previously [6-8]. This elevation may
be attributable to both the derangement of inflammation
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regulation and lifelong exposure of the immune system
to environmental risk factors such as smoking, aging,
hypertension, and diabetes [8-10]. However, previous stu-
dies that demonstrated positive correlations of cytokine
levels with aging were performed in general aging popu-
lations that may have been influenced by various envir-
onmental factors and underlying diseases. Additionally,
data regarding cytokine profiling in the elderly have been
limited to a small subset of cytokines. In this study, we
compared the profiles of 22 cytokines, chemokines, and
growth factors in a case-controlled study group of a gen-
der-matched, healthy cohort of 55 subjects over the age
of 65 (Median age 68) and 55 subjects under the age of
45 (median age 34). The levels of the cytokines, chemo-
kines, and growth factors were analyzed using multi-
plexed bead-based immunoassays.
Methods
Subject population
The study group was comprised of 110 healthy subjects
who were enrolled in the Cardiovascular Genome Center
(male:female = 44:66). The Cardiovascular Genome Cen-
ter is a Korean government-sponsored research project
with the objective of determining the genetic factors
associated with the development of cardiovascular dis-
ease in a large, prospective study group. The study sub-
jects were enrolled in the Cardiovascular Genome Center
cohort as healthy control subjects. The study subjects did
not have any past histories of hypertension, diabetes mel-
litus, cardiovascular disease, cerebrovascular disease, can-
cer, chronic renal disease, or any chronic inflammatory
conditions. Group 1 consisted of 55 subjects under the
age of 45 and group 2 consisted of 55 subjects over the
age of 65. The study subjects were not permitted to per-
form strenuous exercise or drink alcoholic beverages
24 h before the laboratory test. The study subjects were
also instructed to avoid eating or drinking anything
except water during the testing period. Written, informed
consent was obtained from all patients and the protocol
was approved by the Institutional Review Board of Yonsei
University College of Medicine (4-2001-0039). Research
was conducted in compliance with the Helsinki
Declaration.
Blood collection
Blood samples were obtained from the forearm of each
subject via the anticubital vein after a minimum of 12
hours of fasting. Samples were collected in EDTA-treated
and plain tubes.
The methods for determining the concentrations of
each lipid parameter were based on an enzymatic method
(Hitachi 7600-110, Hitachi Co., Japan) that analyzed total
cholesterol and triglyceride levels. After precipitation of
serum chylomicron, LDL, and VLDL with dextran
sulfate-magnesium, the HDL-C remaining in the super-
natant fluid was measured using the enzymatic method
(Hitachi 7600-110). LDL cholesterol levels were calcu-
lated using the Friedewald formula with serum triglycer-
ide concentrations less than 4.52 mol/L (400 mg/mL)
[11].
Anthropometric and blood pressure measurements
The body weight and height of each undressed and
barefoot subject were measured in the morning. After 5
minutes of rest, the brachial blood pressure was mea-
sured from the dominant arm using an OMRON HEM
7080 IT while the subject remained seated. The average
of three measurements was recorded for each subject.
Multiplex bead-based immunoassay
Simultaneous assessment of serum concentrations of
epidermal growth factor (EGF), fibroblast growth factor
2 (FGF2), FMS-like tyrosine kinase 3 ligand (Flt-3L),
granulocyte colony-stimulating factor (G-CSF), granulo-
cyte-monocyte colony-stimulating factor (GM-CSF),
interferon-a2 (IFN-a2), INF-g, IL-10, IL-15, IL-17, IL-
1b, IL-2, IL-6, IL-8, INF-g inducible protein 10 (IP-10),
monocyte chemoattractant protein-1 (MCP-1), macro-
phage inflammatory protein-1b (MIP-1 b), platelet-
derived growth factor-AA (PDGF-AA), soluble CD40
ligand (sCD40L), transforming growth factor alpha
(TGF-a), TNF-a, and vascular endothelial growth factor
(VEGF) was performed using commercially-available
multiplex bead-based sandwich immunoassay kits
(MPXHCYTO-60K-25, Millipore, Billerica, MA) as per
the manufacturer’s instructions. Briefly, plasma samples
(25 μL/well) or standards (25 μL well) were incubated
with 25 μL of the pre-mixed bead sets in pre-wetted 96-
well microtiter plates at 4°C overnight. After washing,
25 μL of the fluorescent detection antibody mixture was
added for 30 min and 25 μL of streptavidin-phycoery-
thrin was added to each well for an additional 30 min at
room temperature. A range of 3.2-10,000 pg/mL recom-
binant cytokines was used to establish standard curves
and to maximize the sensitivity and dynamic range of
the assay. Cytokine levels were determined using a
Luminex IS 100 (Luminex, Austin, TX), and the data
were reported as median fluorescent intensities.
Statistical analysis
Results are expressed as means ± standard deviation. In
this study, comparisons of discrete variables were made
using the chi-square method and t-tests were used for
continuous variables. Because the distribution of the
cytokines was skewed, a log transformation of the cyto-
kines was performed for independent t-tests and partial
correlation analyses. For the partial correlation analysis,
the correlation between aging and serum biomarkers
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was assessed while controlling for gender, smoking,
body mass index (BMI), fasting blood glucose (FBG),
systolic blood pressure (SBP), total cholesterol, HDL
cholesterol (HDL), triglyceride (TG), and serum creati-
nine levels. A two-tailed value of P < 0.05 was consid-
ered statistically significant. All statistical analyses were
performed using SPSS 13.0 (SPSS Inc., Chicago, IL).
Results
Compared to the younger subjects in group 1, the
elderly subjects in group 2 were associated with signifi-
cantly higher SBP, total cholesterol, TG, serum albumin,
serum blood urea nitrogen (BUN) and serum creatinine
(Table 1). Comparison of the serum concentration of 22
cytokines-chemokines-growth factors demonstrated that
sCD40L (group 2: 20370.6 ± 71662.0 pg/mL vs group 1:
2205.8 ± 4699.2 pg/mL, P value = 0.016) and TGF-a
(group 2: 4.9 ± 4.8 pg/mL vs group 1: 3.2 ± 4.0 pg/mL,
P value = 0.026) were significantly higher in the elderly
subjects, whereas G-CSF (group 1: 14.7 ± 13.2 pg/mL vs
group 2: 9.9 ± 8.8 pg/mL, P-value = 0.009), GM-CSF
(group 1: 40.9 ± 108.6 pg/mL vs group 2: 20.3 ± 60.4
pg/mL, P value = 0.021) and MCP-1 (group 1: 213.5 ±
100.7 pg/mL vs group 2: 168.0 ± 73.0 pg/mL, P value =
0.027) were significantly lower in the elderly subjects
(Table 2). The serum level of EGF, FGF-2, Flt-3L, INF-
A2, INF-g, IL-10, IL-15, IL-17, IL-1b, IL-2, IL-6, IL-8,
IP-10, MIP-1b, PDGF-AA, TNF-a and VEGF showed
no significant difference (Table 2). The partial correla-
tion analysis demonstrating the correlation between
cytokines-chemokines-growth factors when controlled
for gender, SBP, total cholesterol, HDL, TG and serum
creatinine demonstrated that G-CSF, GM-CSF and
MCP-1 has a significant negative correlation with age
whereas sCD40L and TGF-a has a significant, positive
correlation (Table 3, Figure 1).
Discussion
To our knowledge, this is the first study that has com-
pared extensive profiles of cytokines, including chemo-
kines and growth factors, in healthy elderly and young
subjects. As compared to the younger subjects in group
1, the elderly subjects had significantly higher SBP, total
cholesterol, TG, serum albumin, serum blood urea
nitrogen (BUN), and serum creatinine levels (Table 1).
Comparison of the serum concentrations of 22 cyto-
kines, chemokines, and growth factors demonstrated
that sCD40L and TGF-a levels were significantly higher
in the elderly subjects, whereas G-CSF, GM-CSF, and
MCP-1 were significantly lower in the elderly subjects
(Table 2). The serum levels of EGF, FGF-2, Flt-3L, INF-
a2, INF-g, IL-10, IL-15, IL-17, IL-1b, IL-2, IL-6, IL-8,
IP-10, MIP-1b, PDGF-AA, TNF-a, and VEGF showed
no significant differences between the two groups (Table
2). The partial correlation analysis demonstrating the
correlation between the levels of the cytokines, chemo-
kines, and growth factors when controlled for gender,
SBP, total cholesterol, HDL, TG, and serum creatinine
levels further indicated that G-CSF, GM-CSF, and
MCP-1 had significant negative correlations with age,
whereas sCD40L and TGF-a had significant positive
correlations (Table 3 and Figure 1).
There was a lack of association of IL-6 levels with
aging in the healthy study populations (Table 2), which
is in concordance with previous studies [12,13]. How-
ever, unlike our findings that indicated no significant
association of TNF-a, IL-6, and IL-1b levels with age,
some previous studies have indicated that these cytokine
levels are elevated in elderly subjects as compared to
younger subjects [8,14-16]. A likely reason for the dis-
crepancy is that in the previous studies, the elderly sub-
jects were not controlled for associated diseases, such as
hypertension and diabetes, which could increase inflam-
mation. In a study by Ferrucci et al., controlling for car-
diovascular risk factors attenuated the regression
coefficient between aging and IL-6 [8]. In contrast to
that study, we excluded subjects with previous histories
of hypertension, cardiovascular disease, cerebrovascular
disease, diabetes mellitus, cancer, or chronic renal dis-
ease, which minimized the confounding effects of con-
comitant disease processes that could alter the
inflammatory state of the study patients. Additionally, in
the study by Ferrucci et al., the highest level of IL-6 was
in subjects over the age of 85, whereas the differences in
IL-6 levels between subjects 65-74 years of age and
patients 20-49 years of age was not as large [8]. The
Table 1 Average baseline clinical characteristics of
patients
Group 1
(Age < 45)
Group 2
(Age ≥ 65)
P-valueb
Gender (male:female) 23:32 23:32
Age 34.8 ± 5.7 70.4 ± 4.9 < 0.001
SBPb(mmHg) 115 ± 13 135 ± 19 < 0.001
DBP (mmHg) 75 ± 9 77 ± 11 0.383
BMI (kg/m2) 22.9 ± 3.6 23.3 ± 3.4 0.526
Smoking (%) 21 (38.2%) 6 (10.9%) 0.001
T chol (mg/dL) 192 ± 30 194 ± 35 0.033
TG (mg/dL) 110 ± 66 162 ± 122 0.007
HDL (mg/dL) 50 ± 12 51 ± 11 0.838
FBG (mg/dL) 84.8 ± 10.4 98.7 ± 38.3 0.011
Albumin (g/dL) 4.7 ± 0.3 4.5 ± 0.3 < 0.001
BUN (mg/dL) 11.7 ± 2.6 15.2 ± 3.8 < 0.001
Cr (mg/dL) 0.68 ± 0.17 0.79 ± 0.23 0.007
aDifferences with P < 0.05 are considered significant.
bAbbreviations; SBP: Systolic blood pressure, DBP; diastolic blood pressure,
BMI: body mass index, T chol: Total cholesterol, TG: Triglyceride, HDL: High
density lipoprotein, FBS: Fasting blood glucose, BUN: Blood urea nitrogen, Cr:
Creatinine
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average age of the elderly subjects in this study was 70.4.
Therefore, the lack of a very elderly population may be
another possible explanation for the discrepancy in
results.
This is the first study to demonstrate that sCD40L levels
are significantly associated with aging (Tables 2 and 3 and
Figure 1). The CD40/CD40L system belongs to the tumor
necrosis factor superfamily and is a key pathway that links
inflammation and atherothrombosis [17]. CD40 and
CD40L are expressed in a variety of cell types, including
platelets, vascular smooth muscle cells (VSMC), and
immune cells [17,18]. Increased interactions between
CD40 and CD40L may result in increased expression of
cell adhesion molecules on endothelial cells and VSMCs,
which subsequently results in increased vascular inflam-
mation. Additionally, sCD40L and CD40 interactions
increase oxidative stress and endothelial dysfunction,
which may also contribute to an increase in the inflamma-
tory cascade [17,19]. Increased secretion of sCD40L may
be one explanation for the increased inflammation asso-
ciated with aging, and may be a pathway that links aging
with an increased risk of atherothrombosis.
TGF-a, a member of the EGF family, is a potent mito-
gen and chemotactic factor [20], and was positively cor-
related with aging (Tables 2 and 3 and Figure 1). TGF-a
binds to the EGF receptor with a high affinity [21] and
is indispensable for the proper development of many tis-
sues and organs, wound healing, bone resorption, and
angiogenesis [22]. TGF-a is implicated in numerous dis-
ease states, including coronary artery diseases, cystic
fibrosis, psoriatic lesions, oral leukoplakia, submucosal
fibrosis, Barrett’s esophagus syndrome, and cancer [22].
Recent results also implicate this growth factor in the
development of certain diabetic complications, such as
atherosclerosis [23]. Though it is unknown whether
TGF-a plays an important role in regulating homeosta-
sis and/or diseases in aged subjects, increased serum
levels of this cytokine in the elderly population may play
Table 2 Serum levels of cytokines, chemokines, and growth factors according to age
Cytokines
(pg/ml)
Group 1
(Age < 45)
Group 2
(Age ≥ 65)
P-valuea
G-CSF 14.7 ± 13.2b (0.03-75.8) 9.9 ± 8.8 (0.03-35.2) 0.009
GM-CSF 40.9 ± 108.6 (0.5-728.1) 20.3 ± 60.40 (0.50-415.1) 0.021
MCP 1 213.5 ± 100.7 (27.9-667.8) 168.0 ± 73.0 (39.34-355.9) 0.027
sCD40L 2205.8 ± 4699.2 (268.6-27703.8) 20370.6 ± 71662.0 (115.8-380396.7) 0.016
TGF-a 3.2 ± 4.0 (0.93-26.8) 4.9 ± 4.8 (0.86-20.8) 0.026
EGF 31.3 ± 35.9 (3.2-210.5) 61.0 ± 65.1 (3.20-251.6) 0.073
FGF-2 18.9 ± 11.3 (6.7-65.6) 20.1 ± 13.9 (3.20-72.83) 0.863
Flt-3L 10.2 ± 10.1 (0.84-59.3) 13.2 ± 15.9 (0.03-78.42) 0.759
IFN-a2 21.3 ± 22.6 (2.42-102.2) 33.3 ± 70.2 (2.42-449.2) 0.822
IFN-g 13.1 ± 22.7 (0.14-126.8) 10.3 ± 18.4 (1.09-117.7) 0.948
IL-10 1.32 ± 3.06 (0.01-19.8) 1.58 ± 6.17 (0.01-41.7) 0.325
IL-15 3.04 ± 2.17 (1.25-13.1) 3.49 ± 4.31 (1.32-28.9) 0.668
IL-17 6.53 ± 7.42 (1.58-37.8) 12.2 ± 37.9 (1.43-275.1) 0.640
IL-1b 2.04 ± 4.93 (0.17-24.) 2.52 ± 7.41 (0.17-39.0) 0.645
IL-2 5.13 ± 2.31 (2.88-18.3) 5.58 ± 4.17 (3.06-32.1) 0.601
IL-6 2.91 ± 6.45 (0.16-37.7) 2.57 ± 5.22 (0.16-31.5) 0.750
IL-8 23.9 ± 29.7 (4.2-132.6) 27.6 ± 43.9 (4.76-217.0) 0.995
IP-10 462.2 ± 364.7 (145.3-2152.2) 451.3 ± 256.4 (149.8-1394.8) 0.673
MIP-1b 40.5 ± 38.8 (3.2-227.2) 40.4 ± 33.6 (3.20-231.1) 0.633
PDGF-AA 1528.3 ± 878.8 (140.6-3290.2) 1615.3 ± 1125.0 (55.3-3421.7) 0.485
TNF-a 3.21 ± 4.04 (0.93-26.8) 4.94 ± 4.79 (0.86-20.8) 0.916
VEGF 114.9 ± 147.1 (13.1-864.1) 100.5 ± 75.4 (6.9-329.3) 0.853
aDifferences with P < 0.05 are considered significant.
bAverage concentrations ± standard deviation in pg/mL.
Table 3 Partial correlation between aging and cytokines
controlled for gender, smoking, body mass index, fasting
blood glucose, SBP, total cholesterol, HDL, triglyceride,
and creatinine levels
Correlation coefficient P-value*
EGF 0.078 0.451
G-CSF -0.214 0.037
GM-CSF -0.297 0.003
MCP-1 -0.293 0.004
Soluble CD40L 0.277 0.007
TGFa 0.261 0.011
* P < 0.05 is considered significant.
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a pathophysiological role in vascular remodeling and
atherogenesis.
Monocytes and neutrophils, key components of the
first line of defense, are the first inflammatory cells
recruited to local tissue sites in response to infection or
inflammation. Both G-CSF and GM-CSF are essential
for leukocyte generation from hematopoietic stem cells,
and are important mediators of the host response to
infection. G-CSF and GM-CSF regulate other cell types
in addition to neutrophils, such as monocytes, natural
killer cells, and dendritic cells [24]. Like most growth
factors and cytokines, G-CSF modulates cytokine pro-
files that alter the composition and function of immune
cell populations. The serum levels of G-CSF and GM-
CSF are often elevated in response to infection, suggest-
ing that these hematopoietic cytokines play key roles in
immunity [25]. The age-related decrease in circulating
G-CSF and GM-CSF levels seen here may contribute to
the impaired inflammatory responses and recruitment of
leukocytes often seen in response to infections in elderly
populations.
MCP-1 (CCL2), a member of the CC chemokine
family, regulates monocyte migration by promoting their
exit from the bone marrow into the circulation or from
circulation to the site of inflammation [26,27]. An ele-
vated baseline level of MCP-1 is associated with acute
coronary syndromes [28]. However, the age-related
decline of circulating MCP-1 seen in our study (Tables 2
and 3) is in sharp contrast to other reports that showed
increased levels in aged populations [29,30]. This discre-
pancy may be due to the rigid selection criteria imposed
in the current study to exclude patients with histories of
hypertension, diabetes, or other disease-related condi-
tions. The decreased production of G-CSF, GM-CSF, and
possibly MCP-1 in the elderly population may partly
explain the age related reduction of circulating
Figure 1 Simple correlation between age and serum biomarkers (sCD40L, G-CSF, GM-CSF, and TGF-a in pg/mL). The × axis is age. The Y
axis consists of log transformed sCD40L, G-CSF, GM-CSF and TGF-a. Simple correlation analysis was performed between age and the cytokines.
Age showed significant positive correlation with log transformed sCD40L (R = 0.257, P = 0.007) and log transformed TGF-a (R = 0.232, P =
0.015), whereas age showed significant negative correlation with log transformed G-CSF (R = -0.232, P = 0.016) and log transformed GM-CSF
(R = -0.249, P = 0.009).
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monocytes and other leukocytes often observed in aged
populations [31].
One of the limitations of the study is the fact that we
could not match the percentage of smokers in the study
population. However, we tried to minimize the influence
of smoking on the levels of cytokines by controlling for
smoking in the partial correlation analysis.
Conclusions
Aging was associated with significant increases in the
serum concentrations of sCD40L and TGF-a and signif-
icant decreases in the serum concentrations of G-CSF,
GM-CSF, and MCP-1. Future studies will focus on
understanding the significance of these age-related
changes in circulating cytokines, chemokines, and other
biological markers and their potential contribution to
the development of various age-associated diseases.
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